POAI Predictive Oncology Inc: Earnings per share for the last 12 months
Predictive Oncology management is integrating AI modeling into oncology, transitioning from science to commercialization. The year-over-year change in EPS (TTM) illustrates this trend, where -163.00 represents the latest metric level. The company is accelerating drug discovery via the largest tumor dataset, meeting the growing demand from biotech behemoths to optimize preclinical R&D research.
Financial and market metric breakdowns for Predictive Oncology Corp (POAI)
- market price and analyst price targets:
- company stock capitalization data:
- book capitalization indicators:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Predictive Oncology|POAI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Predictive Oncology|POAI - Company Debts|Debt to Book Value Predictive Oncology Inc|POAI - Company Long-Term Debts|Short-Term Debt Predictive Oncology|Immediate Liquidity Ratio predictive-oncology.com
- business earnings and investment ratios data:
POAI - Net Income|Future Net Profit Predictive Oncology|POAI - Price to Earnings Ratio|Market Cap to Projected Earnings Predictive Oncology|POAI - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Predictive Oncology Inc|POAI - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Predictive Oncology|POAI - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months predictive-oncology.com|POAI - Earnings growth in current year|Projected earnings per share growth rate for next year Predictive Oncology
Initial company analysis:Predictive Oncology
This indicator measures the percentage change in net earnings per share over a rolling year, smoothing out quarterly gaps to identify the true earnings trend. By analyzing the year-over-year EPS growth dynamics over a rolling period, investors can see how the high B2B authority of the Predictive Oncology (POAI) AI platform in oncopharmacology transforms into tangible financial results and increased shareholder value.
Competitor analysis for Predictive Oncology
Net earnings per share for the last four quarters intuitive.com ISRG|Danaher (DHR) - Earnings per share for the last twelve months|Earnings per share for the last 12 months BDX|Earnings per share for the last twelve months STERIS Corporation|West Pharma Corp (WST) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months BAX (Baxter International)|Earnings per share for the last four quarters MASI|Earnings per share for the last twelve months Stevanato Group STVN|Earnings per share for the trailing year TFX|MMSI: Net earnings per share for the last 12 months|NVST - Net earnings per share (EPS TTM)|ICU Medical, Inc. (ICUI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months dentsplysirona.com|LMAT (LeMaitre Vascular) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AtriCure Inc ATRC|Earnings per share for the last twelve months STAAR Surgical Corp (STAA)|ChromaDex Corporation - Earnings per share for the last 12 months|ZimVie Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANGO (angiodynamics.com)|CERS - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Alpha Teknova TKNO|Monogram Technologies Inc (MGRM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months STSS (Sharps Technology)|Earnings per share for the last twelve months InfuSystem|UTMD: Earnings per share for the trailing year|Net earnings per share (EPS TTM) KRMD|NYXH - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) MBOT (Microbot Medical Inc)|PDEX: Earnings per share for the last 12 months|Zentek Ltd. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters elutia.com ELUT|MLSS: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months NEXGEL Inc.|Net earnings per share for the last 12 months RVP|HBIO (Harvard Bioscience Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) FEMY|Net earnings per share for the last four quarters meihuamed.com|Callan JMB - Net earnings per share for the last 12 months|Atrion Corp. - Earnings per share for the last twelve months|NeuroMetrix Corp - Net earnings per share (EPS TTM)
